- $4.67bn
- $5.50bn
- $8.87bn
- 85
- 93
- 49
- 90
Annual income statement for Nov, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6,090 | 5,524 | 7,237 | 8,583 | 8,870 |
| Cost of Revenue | |||||
| Gross Profit | 434 | 774 | 1,334 | 1,833 | 2,010 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 8,515 | 5,658 | 6,973 | 7,932 | 7,994 |
| Operating Profit | -2,425 | -134 | 264 | 651 | 876 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2,779 | -230 | 238 | 612 | 831 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2,824 | -245 | 155 | 985 | 635 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2,542 | -250 | 155 | 993 | 635 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2,542 | -250 | 155 | 993 | 635 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -4.17 | -0.636 | 0.64 | 2.53 | 1.39 |
| Dividends per Share |